{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:15Z","timestamp":1793686335263,"version":"4.5.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"British Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"US National Institute of Health"},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","award":["33014"],"award-info":[{"award-number":["33014"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Du Pont Pharma"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["PG08\/008"],"award-info":[{"award-number":["PG08\/008"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.atherosclerosis.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T14:55:23Z","timestamp":1361199323000},"page":"243-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Antibodies to citrullinated peptides and risk of coronary heart disease"],"prefix":"10.1016","volume":"228","author":[{"given":"Geraldine","family":"Cambridge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayshree","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9822","key":"10.1016\/j.atherosclerosis.2013.02.009_bib1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis","volume":"379","author":"Hingorani","year":"2012","journal-title":"Lancet"},{"issue":"9822","key":"10.1016\/j.atherosclerosis.2013.02.009_bib2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s10067-007-0548-7","article-title":"Atherosclerosis and inflammation: insights from rheumatoid arthritis","volume":"26","author":"Chung","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib4","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: a posttranslational modification in health and disease","volume":"38","author":"Gyorgy","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1443.013","article-title":"Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis","volume":"1143","author":"van Venrooij","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jbspin.2004.07.004","article-title":"Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis","volume":"71","author":"Sebbag","year":"2004","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3899\/jrheum.101143","article-title":"Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide","volume":"38","author":"El-Barbary","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2004.12.026","article-title":"A\u00a0comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study","volume":"181","author":"Cooper","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0038-1650364","article-title":"Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease","volume":"75","author":"Miller","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib13","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/1529-0131(199907)42:7<1339::AID-ANR6>3.0.CO;2-Y","article-title":"Estimating the incidence of rheumatoid arthritis: trying to hit a moving target?","volume":"42","author":"Wiles","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/jsbi.1999.4200","article-title":"Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination","volume":"129","author":"Beniac","year":"2000","journal-title":"J\u00a0Struct Biol"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","article-title":"Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis","volume":"23","author":"Klareskog","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.atherosclerosis.2013.02.009_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/smim.1997.0076","article-title":"B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis","volume":"9","author":"Berek","year":"1997","journal-title":"Semin Immunol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T17:10:51Z","timestamp":1562692251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0021915013001196"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.02.009","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to citrullinated peptides and risk of coronary heart disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}